- Directory
- March 2025
Global
€2319EUR$2,439USD£1,948GBP
- Training
- January 2025
- 3 Days
Global
From €1752EUR$1,843USD£1,472GBP
- Training
- April 2025
- 2 Days
Global
From €1748EUR$1,839USD£1,469GBP
- Training
- December 2024
- 3 Days
Global
From €2216EUR$2,331USD£1,862GBP
- Training
- August 2024
- 2 Days
Global
From €1869EUR$1,966USD£1,570GBP
- Training
- June 2024
- 2 Days
Global
From €1752EUR$1,843USD£1,472GBP
- Report
- February 2024
- 150 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Training
- May 2025
- 1 Day
Global
From €582EUR$613USD£489GBP
- Training
- February 2024
- 2 Days
Global
From €2757EUR$2,900USD£2,316GBP
- Training
- December 2023
- 2 Days
Global
From €1518EUR$1,597USD£1,275GBP
- Training
- June 2024
- 90 Minutes
Global
- Training
- January 2024
- 2 Days
Global
From €2757EUR$2,900USD£2,316GBP
- Training
- December 2023
- 2 Days
Global
From €2757EUR$2,900USD£2,316GBP
- Training
- November 2023
- 2 Days
Global
€3506EUR$3,688USD£2,945GBP
- Training
- September 2023
- 3 Days
Global
From €2757EUR$2,900USD£2,316GBP
- Training
- September 2023
- 3 Days
Global
From €1752EUR$1,843USD£1,472GBP
- Webinar
- July 2023
- 90 Minutes
Global
From €338EUR$355USD£284GBP
- Training
- April 2023
- 2 Days
Global
From €1050EUR$1,105USD£882GBP
- Webinar
- December 2022
- 90 Minutes
Global
- Training
- September 2021
- 1 Day
Global
From €950EUR$999USD£798GBP

The FDA Compliance market within the context of Drug Discovery is a highly regulated industry that requires companies to adhere to strict guidelines in order to bring new drugs to market. Companies must ensure that their products meet the safety and efficacy standards set by the FDA, as well as comply with the Good Manufacturing Practices (GMP) regulations. Companies must also ensure that their products are properly labeled and packaged, and that they are properly stored and transported. Additionally, companies must ensure that their products are properly tested and monitored throughout the drug development process.
Companies in the FDA Compliance market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more